Researchers from the University of South Australia, McMaster University in Canada, and Texas A&M University have shown that curcumin can be delivered effectively into human cells via nanoparticles. The researchers have shown in animal experiments that nanoparticles containing curcumin not only prevents cognitive deterioration but also reverses the damage. This finding paves the way for clinical development trials for Alzheimer’s disease.
An official website of the United States government.